These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35396602)

  • 1. Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
    Sherlock SP; Palmer J; Wagner KR; Abdel-Hamid HZ; Bertini E; Tian C; Mah JK; Kostera-Pruszczyk A; Muntoni F; Guglieri M; Brandsema JF; Mercuri E; Butterfield RJ; McDonald CM; Charnas L; Marraffino S
    J Neurol; 2022 Aug; 269(8):4421-4435. PubMed ID: 35396602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.
    Sherlock SP; Zhang Y; Binks M; Marraffino S
    Biomark Med; 2021 Jun; 15(10):761-773. PubMed ID: 34155911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy.
    Wagner KR; Abdel-Hamid HZ; Mah JK; Campbell C; Guglieri M; Muntoni F; Takeshima Y; McDonald CM; Kostera-Pruszczyk A; Karachunski P; Butterfield RJ; Mercuri E; Fiorillo C; Bertini ES; Tian C; Statland J; Sadosky AB; Purohit VS; Sherlock SP; Palmer JP; Binks M; Charnas L; Marraffino S; Wong BL
    Neuromuscul Disord; 2020 Jun; 30(6):492-502. PubMed ID: 32522498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy.
    Sherlock SP; Palmer J; Wagner KR; Abdel-Hamid HZ; Tian C; Mah JK; Muntoni F; Guglieri M; Butterfield RJ; Charnas L; Marraffino S
    Sci Rep; 2022 Nov; 12(1):18762. PubMed ID: 36335191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in magnetic resonance imaging biomarkers of the gluteal muscle groups and functional ability in Duchenne muscular dystrophy: a 12-month cohort study.
    Song Y; Xu K; Xu HY; Guo YK; Xu R; Fu H; Yuan WF; Zhou ZQ; Xu T; Chen XJ; Wang YL; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Dec; 53(13):2672-2682. PubMed ID: 37889296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.
    Willcocks RJ; Rooney WD; Triplett WT; Forbes SC; Lott DJ; Senesac CR; Daniels MJ; Wang DJ; Harrington AT; Tennekoon GI; Russman BS; Finanger EL; Byrne BJ; Finkel RS; Walter GA; Sweeney HL; Vandenborne K
    Ann Neurol; 2016 Apr; 79(4):535-47. PubMed ID: 26891991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
    Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
    Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.
    Barnard AM; Willcocks RJ; Finanger EL; Daniels MJ; Triplett WT; Rooney WD; Lott DJ; Forbes SC; Wang DJ; Senesac CR; Harrington AT; Finkel RS; Russman BS; Byrne BJ; Tennekoon GI; Walter GA; Sweeney HL; Vandenborne K
    PLoS One; 2018; 13(3):e0194283. PubMed ID: 29554116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population PK and PD Analysis of Domagrozumab in Pediatric Patients with Duchenne Muscular Dystrophy.
    Wojciechowski J; Purohit VS; Harnisch LO; Dua P; Tan B; Nicholas T
    Clin Pharmacol Ther; 2022 Dec; 112(6):1291-1302. PubMed ID: 36104012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance.
    Nair KS; Lott DJ; Forbes SC; Barnard AM; Willcocks RJ; Senesac CR; Daniels MJ; Harrington AT; Tennekoon GI; Zilke K; Finanger EL; Finkel RS; Rooney WD; Walter GA; Vandenborne K
    J Neuromuscul Dis; 2022; 9(3):423-436. PubMed ID: 35466946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.
    Forbes SC; Willcocks RJ; Triplett WT; Rooney WD; Lott DJ; Wang DJ; Pollaro J; Senesac CR; Daniels MJ; Finkel RS; Russman BS; Byrne BJ; Finanger EL; Tennekoon GI; Walter GA; Sweeney HL; Vandenborne K
    PLoS One; 2014; 9(9):e106435. PubMed ID: 25203313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Gerhalter T; Gast LV; Marty B; Martin J; Trollmann R; Schüssler S; Roemer F; Laun FB; Uder M; Schröder R; Carlier PG; Nagel AM
    J Magn Reson Imaging; 2019 Oct; 50(4):1103-1113. PubMed ID: 30719784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.